Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

ClinicalTrials.gov ID: NCT02704858

Public ClinicalTrials.gov record NCT02704858. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 17, 2026, 3:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Phase 1/2A Dose Escalation Study of Safety and Efficacy of NEO100 in Recurrent or Progressive Grade III or Grade IV Gliomas With IDH1 Mutation

Study identification

NCT ID: NCT02704858
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: Neonc Technologies, Inc.; Industry
Enrollment: 49 participants

Conditions and interventions

Conditions

Glioblastoma Multiforme

Interventions

Perillyl alcohol Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 31, 2017
Primary completion: Mar 29, 2026
Completion: May 31, 2026
Last update posted: Mar 1, 2026

2017 – 2026

United States locations

U.S. sites: 12
U.S. states: 10
U.S. cities: 11

Facility	City	State	ZIP	Site status
University of Southern California	Los Angeles	California	90033	Recruiting
Saint John Cancer Institute	Santa Monica	California	90404	Recruiting
Georgia Cancer Center (Augusta University)	Augusta	Georgia	30912	Recruiting
Ochsner Health	New Orleans	Louisiana	70121	Recruiting
Atlantic Health (Overlook Medical Center)	Summit	New Jersey	07901	Recruiting
Northwell Health	New York	New York	10016	Recruiting
Wake Forest University Health Sciences	Winston-Salem	North Carolina	27157	Recruiting
Cleveland Clinic	Cleveland	Ohio	44333	Recruiting
Baylor Scott & White Health	Dallas	Texas	75061	Recruiting
University of Texas Southwestern Medical Center	Dallas	Texas	75235	Recruiting
University of Washington Medical Center	Seattle	Washington	98105	Not yet recruiting
University of Wisconsin Hospital and Clinic	Madison	Wisconsin	53792	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02704858, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 1, 2026 · Synced May 17, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02704858 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →